Literature DB >> 16455217

Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit.

Joan I A Campbell1, Alicja Mortensen, Per Mølgaard.   

Abstract

The toxicity and anti-diabetic properties of an aqueous plant extract made by boiling Rauwolfia vomitoria foilage and Citrus aurantium fruits were evaluated in mice. A single dosage corresponding to 70x the human-daily-dose was non-toxic when administered to 6-week-old NMRI lean mice or 6- or 11-week-old C57BL/6J lean mice. Daily treatment of 11-week-old C57BL/KsBom-db (db/db) genetic diabetic mice with a dose corresponding to 10x human-daily-dose for 6 weeks facilitated a significant weight loss as compared to the untreated controls. During treatment, the db/db mice were maintained on the carbohydrate-deficient Altromin C1009 diet. Although the food intake in the treated mice was not statistically significant from that in the controls, the treated animals had significantly higher serum triglyceride contents, suggesting that the treatment induced lipid mobilization from internal stores. Moreover, the fatty acid profile of the eyes from the treated animals showed a significant reduction in total fatty acid content accompanied by a 33% reduction in estimated Stearoyl-CoA desaturase activity (p = 0.039) as compared with controls. The fatty acid mobilization and a protection of the brittle C57BL/KsBom-db pancreas were observed 5 weeks after cessation of treatment when the treated animals were maintained on the poorer Altromin C1009 diet.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455217     DOI: 10.1016/j.jep.2005.12.029

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice.

Authors:  Sunday Agba Bisong; Richard Earl Brown; Eme Effiom Osim
Journal:  J Nat Med       Date:  2012-03-30       Impact factor: 2.343

2.  Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.

Authors:  Laura Guasch; Esther Sala; María José Ojeda; Cristina Valls; Cinta Bladé; Miquel Mulero; Mayte Blay; Anna Ardévol; Santiago Garcia-Vallvé; Gerard Pujadas
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

3.  Comparative effects of Rauwolfia vomitoria and chlorpromazine on social behaviour and pain.

Authors:  Sunday Bisong; Richard Brown; Eme Osim
Journal:  N Am J Med Sci       Date:  2011-01

Review 4.  An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent.

Authors:  Ipek Suntar; Haroon Khan; Seema Patel; Rita Celano; Luca Rastrelli
Journal:  Oxid Med Cell Longev       Date:  2018-05-02       Impact factor: 6.543

5.  Bitter Orange (Citrus aurantium Linné) Improves Obesity by Regulating Adipogenesis and Thermogenesis through AMPK Activation.

Authors:  Jinbong Park; Hye-Lin Kim; Yunu Jung; Kwang Seok Ahn; Hyun Jeong Kwak; Jae-Young Um
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

6.  In Vitro Studies on Antioxidant and Anti-Parasitic Activities of Compounds Isolated from Rauvolfia caffra Sond.

Authors:  Dorcas B Tlhapi; Isaiah D I Ramaite; Chinedu P Anokwuru; Teunis van Ree; Heinrich C Hoppe
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

Review 7.  Diabetes and related remedies in medieval Persian medicine.

Authors:  Mohammad M Zarshenas; Sedigheh Khademian; Mahmoodreza Moein
Journal:  Indian J Endocrinol Metab       Date:  2014-03

8.  Antioxidant Capacity, Anticancer Ability and Flavonoids Composition of 35 Citrus (Citrus reticulata Blanco) Varieties.

Authors:  Yue Wang; Jing Qian; Jinping Cao; Dengliang Wang; Chunrong Liu; Rongxi Yang; Xian Li; Chongde Sun
Journal:  Molecules       Date:  2017-07-05       Impact factor: 4.411

9.  Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana.

Authors:  Patrick Amoateng; Emmanuel Quansah; Thomas K Karikari; Alex Asase; Dorcas Osei-Safo; Kennedy Kwami Edem Kukuia; Isaac Kingsley Amponsah; Alexander K Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.